The FDA has recently required drug companies to provide warnings on the labels of all antidepressants because of evidence that these drugs may induce
a. suicidal ideation or behaviors in a small proportion of depressed patients at the beginning of their treatment
b. parkinsonian-like symptoms in elderly patients
c. hypertensive crises when combined with certain foods or other drugs
d. convulsions in certain patients
Question 2
Recent evidence suggests that monoamine oxidase inhibitors have the greatest efficacy in the treatment of
a. atypical depressions
b. schizophrenics
c. manic patients
d. bipolar depressives
Subcutaneous drug administration: (d) the needle is removed and the puncture site is covered with an
First-pass effect: (a) drugs are absorbed; (b) drugs enter hepatic portal circulation and go directl
Barriers that a drug administered by the oral route must cross before interacting with a target ...
The relation between drug tolerance and withdrawal effects. The same adaptive neurophysiological ...
Clinically Significant Drug-Disease Interactions in Dentistry
Drug Label for Erythromycin Ethylsuccinate